Preclinical Studies of Immunogenity, Protectivity, and Safety of the Combined Vector Vaccine for Prevention of the Middle East Respiratory Syndrome

The Middle East Respiratory Syndrome (MERS) is an acute inflammatory disease of the respiratory system caused by the MERS-CoV coronavirus. The mortality rate for MERS is about 34.5%. Due to its high mortality rate, the lack of therapeutic and prophylactic agents, and the continuing threat of the spr...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolzhikova, I. V., Grousova, D. M., Zubkova, O. V., Tukhvatulin, A. I., Kovyrshina, A. V., Lubenets, N. L., Ozharovskaia, T. A., Popova, O., Esmagambetov, I. B., Shcheblyakov, D. V., Evgrafova, I. M., Nedorubov, A. A., Gordeichuk, I. V., Gulyaev, S. A., Botikov, A. G., Panina, L. V., Mishin, D. V., Loginova, S. Y., Borisevich, S. V., Deryabin, P. G., Naroditsky, B. S., Logunov, D. Y., Gintsburg, A. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: A.I. Gordeyev 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604897/
https://www.ncbi.nlm.nih.gov/pubmed/33173601
http://dx.doi.org/10.32607/actanaturae.11042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604897/
https://www.ncbi.nlm.nih.gov/pubmed/33173601
http://dx.doi.org/10.32607/actanaturae.11042

Ejemplares similares